abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding abrdn Life Sciences Investors changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 83 | 2 | 74 | −7 |
| Shares | 9.15M | 25.9K | 8.79M | −335.3K (−3.7%) |
| Value | $141.7M | $402.2K | $147.3M | +$6.04M (+4.3%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held abrdn Life Sciences Investors at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Landscape Capital Management, L.L.C. | 69,030 | $1.16M | 0.08% |
| Z3 Capital Partners, LLC | 66,849 | $1.12M | 0.27% |
| Closed-End Fund Advisors, Inc. | 29,706 | $498.5K | 0.29% |
| Almitas Capital LLC | 19,239 | $322.8K | 0.07% |
| Decision Investments, Inc | 17,654 | $296.2K | 0.32% |
| Invesco Ltd. | 16,367 | $274.6K | 0.00% |
| Evolve Private Wealth, LLC | 11,854 | $198.9K | 0.01% |
| Mercer Global Advisors Inc | 10,527 | $176.7K | 0.00% |
| Pinnacle Wealth Planning Services, Inc. | 1,720 | $28.9K | 0.00% |
| Atlas Capital Advisors LLC | 138 | $2.31K | 0.00% |
| Sound Income Strategies, LLC | 65 | $1.08K | 0.00% |
Sold out (18)
Institutions that held abrdn Life Sciences Investors at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Karpus Management, Inc. | 300,284 | $4.66M |
| Thomas J. Herzfeld Advisors, Inc. | 116,937 | $1.81M |
| Marex Group plc | 56,967 | $883.6K |
| Samalin Investment Counsel, LLC | 18,546 | $287.6K |
| Balyasny Asset Management LLC | 18,340 | $284.5K |
| Cornerstone Advisors, LLC | 11,300 | $175.3K |
| Envestnet Asset Management Inc | 10,301 | $159.8K |
| Future Financial Wealth Managment LLC | 2,000 | $31.0K |
| VSM Wealth Advisory, LLC | 1,572 | $24.4K |
| Parallel Advisors, LLC | 1,001 | $15.5K |
| Bessemer Group Inc | 937 | $15.0K |
| Advisory Services Network, LLC | 852 | $13.2K |
| Principal Securities, Inc. | 768 | $11.9K |
| Rockefeller Capital Management L.P. | 642 | $9.96K |
| WFA of San Diego, LLC | 300 | $4.65K |
| Salem Investment Counselors Inc | 125 | $1.94K |
| Jones Financial Companies LLLP | 125 | $1.85K |
| Quent Capital, LLC | 1 | $16 |
Not filed for Q4 2025 yet (2)
Institutions that held abrdn Life Sciences Investors at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| WNY Asset Management, LLC | 25,704 | $398.7K |
| Creekmur Asset Management LLC | 230 | $3.57K |